Impact of clinical trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Impact of clinical trials in Mexico

Impact of clinical trials in Mexico – Clinical Trial South America

Clinical trials play a vital role in advancing medical knowledge, improving patient care, and driving innovation in healthcare. In recent years, Mexico has emerged as a significant hub for clinical research, offering a range of benefits for both participants and the country’s healthcare system.

This article explores the impact of clinical trials in Mexico, highlighting their contributions to medical advancements, patient access to cutting-edge treatments, economic growth, and regulatory development.

Advancing Medical Knowledge

Clinical trials are crucial for expanding our understanding of diseases, evaluating new treatments, and assessing the safety and efficacy of pharmaceuticals and medical devices. In Mexico, these trials provide a platform for researchers to investigate various health conditions prevalent in the country, such as cardiovascular diseases, diabetes, cancer, and infectious diseases.

By conducting clinical trials locally, researchers can gather valuable data on the efficacy and safety of treatments specific to the Mexican population. This enables healthcare providers to offer tailored interventions, improving patient outcomes and reducing the reliance on extrapolated findings from trials conducted in other regions.

Improved Access to Cutting-Edge Treatments

Participating in clinical trials grants patients access to innovative treatments, often not yet available through standard care. This offers new hope to individuals with limited treatment options or those who have exhausted traditional therapies.

By facilitating participation in clinical trials, Mexico provides its citizens with the opportunity to receive potentially life-saving or life-changing interventions that may otherwise be inaccessible.

Furthermore, clinical trials contribute to the development of new drugs and medical devices. Successful trials lead to regulatory approvals, allowing these advancements to enter the market and benefit patients nationwide. This fosters a culture of innovation in Mexico’s healthcare system, driving progress and ensuring patients have access to the latest therapies.

Impact of clinical trials in Mexico

Impact of clinical trials in Mexico

Impact of clinical trials in Mexico

Economic Growth and Job Creation

The presence of clinical trials in Mexico has a positive impact on the economy. Pharmaceutical companies, contract research organizations (CROs), and academic institutions invest in research infrastructure, equipment, and human resources, creating jobs and stimulating economic growth.

Clinical trials require a range of specialized professionals, including physicians, nurses, research coordinators, and data managers, contributing to employment opportunities and expanding the healthcare workforce.

Moreover, hosting clinical trials attracts foreign investment and enhances Mexico’s reputation as a destination for clinical research. As a result, the country benefits from increased collaborations, knowledge transfer, and technology exchange between international organizations and local research institutions.

These collaborations contribute to the long-term growth of the healthcare sector and foster scientific excellence.

Regulatory Development and Patient Safety

The growing presence of clinical trials in Mexico has prompted the development and enhancement of regulatory frameworks to ensure patient safety and research integrity.

Government agencies, such as the Federal Commission for the Protection against Sanitary Risk (COFEPRIS), have strengthened regulations and guidelines for conducting trials, ensuring adherence to ethical standards and international best practices.

The implementation of rigorous regulatory processes safeguards the rights and welfare of trial participants, promoting transparency and trust among the public. By establishing a robust regulatory environment, Mexico demonstrates its commitment to maintaining high standards in clinical research, attracting further investment and collaborations.


Clinical trials in Mexico have a significant impact on healthcare, research, and the economy. They contribute to medical advancements, offer patients access to cutting-edge treatments, drive economic growth, and foster regulatory development. By embracing clinical research, Mexico positions itself as a key player in global healthcare innovation, ultimately improving patient outcomes and promoting the well-being of its population.

Impact of clinical trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Impact of clinical trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Impact of clinical trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Impact of clinical trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Impact of clinical trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Impact of clinical trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Impact of clinical trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Impact of clinical trials in Mexico

The Cohortias Team

Impact of clinical trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Impact of clinical trials in Mexico

Network & Partnerships